Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Free Light Chains in Heart Failure
Author(s): Akira Matsumori , Toshio Shimada , Hisayoshi Suma , et al Added: 6 days ago

Heart Failure
ESC 25: The HI-PRO Trial
Author(s): Gregory Piazza Added: 9 months ago
ESC Congress 2025 - HI-PRO shows apixaban 2.5mg twice daily reduced the risk of symptomatic recurrent venous thromboembolism when compared to placebo at 12 months.Dr Gregory Piazza (Brigham and Women's Hospital, US) joins us to discuss findings from the HI-PRO trial, evaluating extended-duration low-intensity apixaban versus placebo for secondary prevention in high-risk patients with provoked… View more

Anticoagulation

Vascular Disease and Surgery
Early SGLT2i/MRA Use Benefits Suspected HF Patients
Added: 3 months ago Source:  Cardiac Failure Review Journal
Delays in diagnosis and treatment for patients with suspected heart failure (HF) in the community can lead to preventable hospitalisations and deaths. A new modelling study by Dr Kieran Docherty and colleagues suggests that early initiation of disease-modifying therapies in select patients at the time of an elevated natriuretic peptide test could significantly reduce these adverse outcomes… View more

Intervention

Heart Failure
ASD in Pregnancy and the 2025 ESC Guidelines
Author(s): Grace Hoi Ting Kwok , Kevin Ka-ho Kam Added: 1 month ago

Imaging & Diagnostics

Inherited and Congenital Cardiac Conditions
GDMT & Outcomes in HFrEF: Physician-led Multicentre Experience from Sarawak
Author(s): Rebecca Su Li Chew , Bui Khiong Chung , Hwei Sung Ling , et al Added: 2 months ago

Cardiovascular Kidney Metabolic

Guidelines & Statements
GLP-1 RAs in T2D and Established or High-risk ASCVD
Author(s): Wanwarang Wongcharoen , Rungroj Krittayaphong , Wacin Buddhari , et al Added: 1 year ago

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type
Author(s): Marianna Fontana Added: 1 year ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,… View more

Heart Failure
Digital Therapeutics and Type 2 Diabetes
Author(s): Kayo Waki , Shuya Iwata , Toshimasa Yamauchi , et al Added: 1 year ago

Cardiovascular Kidney Metabolic
Hypertension and Abnormal Renal Function in Type-1 EHRA Valvular AF
Author(s): Rena Winant , Sunu Budhi Raharjo , Rina Ariani , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Importance of Testing for CKD Among Patients With Type 2 Diabetes
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more

Guidelines & Statements

Prevention & Chronic Conditions